SCHOTT Opens Facility in China
SCHOTT began production of glass ampoules, vials, and cartridges at a new facility at the SCHOTT Xinkang headquarters in Zhejiang, China.
SCHOTT began production at a new plant for pharmaceutical packaging in China with an annual production capacity of two billion pieces, the company announced in a press release on Oct. 20, 2017. The plant is managed by the joint venture SCHOTT Xinkang and is located at joint venture headquarters in Jinyun, Zhejiang, China.
The plant highlights the company’s philosophy of keeping production sites close to the customers and markets. It will manufacture high-quality ampoules, vials, and cartridges made of premium glass tubing for the domestic pharma industry.
Source: SCHOTT
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Prokaryotics Licenses Gram-Negative Antibiotic Potentiator from Northern Antibiotics
June 26th 2025Prokaryotics will gain worldwide rights to develop, manufacture, and commercialize NAB741, a non-bioactive polymyxin designed to increase permeability of the outer membrane of Gram-negative bacteria.
